Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 625 phantom stock units through the company's Supplemental Savings Plan on February 13, 2025.

Summary

• On February 13, 2025, Albert Bourla, the Chairman and CEO of Pfizer Inc., acquired 625 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the phantom stock units was $25.64.
• Following the transaction, Bourla directly owns 702,791 shares.
• These units are settled in cash upon separation from service and can be transferred to an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of phantom stock units by the CEO is a routine transaction and indicates continued alignment with the company's performance.

Positives

• The acquisition of phantom stock units by the CEO demonstrates his continued investment in the company's future.
• The Pfizer Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it demonstrates the CEO's continued investment in the company.

Key Dates

Keywords

Form 4, Albert Bourla, Pfizer, PFE, phantom stock units, Supplemental Savings Plan, CEO, acquisition, beneficial ownership